Absence of Lung Immunopathology Following Respiratory Syncytial Virus (RSV) Challenge in Mice Immunized with a Recombinant RSV G Protein Fragment

By Plotnicky-Gilquin H.   Huss T.   Aubry J.-P.   Haeuw J.-F.   Beck A.   Bonnefoy J.-Y.   Nguyen T.N.   Power U.F.  

Virology, Vol. 258, Iss. 1, 1999-05 ,pp. : 128-140

Elsevier

Access to resources Recommend Favorite

Chimeric Subgroup A Respiratory Syncytial Virus with the Glycoproteins Substituted by Those of Subgroup B and RSV without the M2-2 Gene Are Attenuated in African Green Monkeys

By Cheng X.   Zhou H.   Tang R.S.   Munoz M.G.   Jin H.  

Virology, Vol. 283, Iss. 1, 2001-04 ,pp. : 59-68

Elsevier

Access to resources Recommend Favorite

Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection

By Barretto N.   Hallak L.K.   Peeples M.E.  

Virology, Vol. 313, Iss. 1, 2003-08 ,pp. : 33-43

Elsevier

Access to resources Recommend Favorite

Induction of Protective Immunity in Rodents by Vaccination with a Prokaryotically Expressed Recombinant Fusion Protein Containing a Respiratory Syncytial Virus G Protein Fragment

By Power U.F.   Plotnicky-Gilquin H.   Huss T.   Robert A.   Trudel M.   Stahl S.   Uhlen M.   Nguyen T.N.   Binz H.  

Virology, Vol. 230, Iss. 2, 1997-04 ,pp. : 155-166

Elsevier

Access to resources Recommend Favorite

Use of a vesicular stomatitis virus complementation system to analyze respiratory syncytial virus binding

By Klenk K.   Roberts S.R.  

Virus Research, Vol. 90, Iss. 1, 2002-12 ,pp. : 327-335

Elsevier

Access to resources Recommend Favorite